JP
CellFiber will be presenting at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, taking place May 11–15, 2026 in Boston, MA.
The American Society of Gene & Cell Therapy (ASGCT) is the leading professional organization for the advancement of cell and gene therapies.
■ ASGCT 2026 Annual Meeting
DATE
・Meeting Dates: Sunday, May 11 to Thursday, May 15, 2026
VENUE
・Boston’s Thomas M. Menino Convention & Exhibition Center
＜T CELL POSTER＞
・Date: May 13, 5:00–6:30 PM / May 14, 5:00–6:30 PM
・Venue: Poster Hall
・Title: “Alginate hydrogel-based 3D fiber culture platform enables feasible and scalable human CD3 T cell production via CellFiber® technology”
＜iPSC ORAL ABSTRACT PRESENTATION＞
・Date: May 13, 2026 (4:15 PM, 10 min + 5 min Q&A)
・Session Title: Scale-up, scale-out, formulation, supply chains, quality, and logistics I
・Presentation Title: “High-Density Expansion of iPSCs in a Closed and Scalable System Using CellFiber Microfluidic Technology”
・Speaker: Katsuhiko Nakashima, VP of MSAT, CellFiber Co., Ltd.
＜EXHIBITION BOOTH＞
・Booth No.1474
CellFiber Extruder demo unit will be on-site
For more information, please visit https://bit.ly/4cHlEVn
We look forward to connecting with partners, researchers, and innovators across the cell and gene therapy community at ASGCT 2026. Stop by our booth, attend the presentation, or visit our poster sessions to learn more about our latest work in scalable T cell and iPSC manufacturing.
About ASGCT
The American Society of Gene & Cell Therapy (ASGCT) is the leading professional organization for the advancement of cell and gene therapies. ASGCT members are a diverse community of scientists, physicians, patient advocates, and industry professionals dedicated to turning groundbreaking research into life-changing treatments.
Copyright © CellFiber